Suboptimal response to imatinib according to 2006-2009 European LeukaemiaNet criteria: a 'grey zone' at 3, 6 and 12 months identifies chronic myeloid leukaemia patients who need early intervention.
作者信息
Breccia Massimo, Orlandi Sonia M, Latagliata Roberto, Grammatico Sara, Diverio Daniela, Mancini Marco, Loglisci Giuseppina, Salaroli Adriano, Federico Vincenzo, Santopietro Michelina, Alimena Giuliana
出版信息
Br J Haematol. 2011 Jan;152(1):119-21. doi: 10.1111/j.1365-2141.2010.08380.x. Epub 2010 Oct 11.
Abstract
摘要
Zotero 插件